Clinical trial
Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China
NCT01021904 is registered in ClinicalTrials.gov with Chinese Academy of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China
- Lead sponsor
- Chinese Academy of Medical Sciences
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- June 30, 2010
- Completion date
- December 31, 2014
- Enrollment
- 6,200 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cervical cancer, hpv infections, hpv related diseases, precancerous disease of the cervix